Not a good buy right now: long-term trend remains bearish (SMA_200 > SMA_20 > SMA_5) while price is already pushing near resistance (～30.63 vs R2 30.89), limiting immediate upside for an impatient entry.
Intellectia Proprietary Trading Signals: No signal on given stock today (AI Stock Picker: no signal; SwingMax: no recent signal), so there is no “strong-buy” system trigger to override other negatives.
Options positioning looks bullish (low put/call ratios), but options activity is light vs normal, suggesting limited conviction.
Latest reported quarter (2025/Q3) shows a severe YoY deterioration in profitability (Net Income/EPS), which is a fundamental headwind with no news catalysts to offset it.
Technical Analysis
Trend: Bearish structure (SMA_200 > SMA_20 > SMA_5) implies the broader trend is still down despite recent stabilization.
Momentum: MACD histogram is positive (0.0437) and expanding, indicating improving short-term momentum.
RSI: RSI_6 = 67.1 (upper-neutral, near overbought), suggesting upside may be getting stretched short-term.
Levels: Pivot 29.988; Support S1 29.43 (then S2 29.085). Resistance R1 30.545 already exceeded; next resistance R2 30.89—price is close to a likely supply zone.
Pattern-based odds: Similar-pattern projection favors small gains near-term (next day/week) but points to weakness over the next month (-4.65%), aligning with the bearish longer-term MAs.
Volatility: IV30 = 31.69 vs HV = 24.78; IV percentile 16.39 and IV rank 11.76 → implied vol is relatively cheap vs its own history.
Activity/conviction: Today’s option volume (152) is ~45% of 30-day average (muted participation), while open interest looks healthy (17,428 total; ~103% vs avg OI), suggesting positioning exists but today’s flow isn’t aggressive.
Options market skew is bullish (low put/call ratios), and IV is relatively low (could make call structures cheaper if a catalyst emerges).
Near-term statistical pattern shows a modest positive bias over the next day/week.
Neutral/Negative Catalysts
suggests rallies may fade.
Financial Performance
Latest quarter: 2025/Q3.
Revenue: 179.26M, flat YoY (0.00%) → no top-line growth signal.
Profitability: Net Income 105.06M, down -212.72% YoY; EPS 0.63, down -212.50% YoY → sharp deterioration vs prior year.
Gross margin: reported at 100 and flat YoY (0.00%) → not showing improvement that would offset the earnings drop.
Overall: financial trend (especially EPS/Net Income) is a material negative for buying aggressively right now.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating trend or price-target change data was provided, so a Wall Street consensus pro/con view cannot be confirmed from the dataset.
Practical takeaway: with no visible analyst-driven upgrades/targets as a tailwind, the decision leans more heavily on the bearish technical structure and weak latest-quarter profitability trend.
Wall Street analysts forecast MRP stock price to rise
2 Analyst Rating
Wall Street analysts forecast MRP stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 31.840
Low
35
Averages
36.5
High
38
Current: 31.840
Low
35
Averages
36.5
High
38
Citi
Nick Joseph
Buy
maintain
$34 -> $38
AI Analysis
2025-10-29
Reason
Citi
Nick Joseph
Price Target
$34 -> $38
AI Analysis
2025-10-29
maintain
Buy
Reason
Citi analyst Nick Joseph raised the firm's price target on Millrose Properties to $38 from $34 and keeps a Buy rating on the shares.
Lucid Capital
NULL -> Buy
initiated
$40
2025-09-22
Reason
Lucid Capital
Price Target
$40
2025-09-22
initiated
NULL -> Buy
Reason
Lucid Capital initiated coverage of Millrose Properties with a Buy rating and $40 price target. The firm views the company as \"unique\" with a land bank structured as a real estate investment trust, offering an 8% dividend yield. Millrose's growth opportunity in third-party agreements is \"substantial,\" the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MRP
